Clairvoyant is conducting a study for people diagnosed with moderate to severe Alcohol Use Disorder.

The study seeks to determine the safety and effectiveness of Psilocybin Assisted Psychotherapy in the treatment for Alcohol Use Disorder.

The total duration of the clinical trial will be 29 weeks, including a 5 week screening period, with 13 visits to the research site. The following minimum criteria must be met in order to participate:  

  • Individuals between the ages of 18 to 70 years old.

  • You are located in or near the cities listed below

  • You have moderate to severe alcohol dependence.

  • You use alcohol almost daily and in large amounts.

  • You wish to decrease the number of occasions in which you drink and/or the number of alcohol units you consume.

  • You do not have hepatitis, kidney failure, or serious liver or heart problems.

  • You are not pregnant.

If you meet the above criteria, and are interested in participating, please contact the site closest to you.

Visit our page at clinicaltrials.gov here.

Confidentiality Notice: Your inquiry will be directed to an independent contract research organization (CRO) retained by Clairvoyant. Our CRO will maintain the information you provide in strictest confidence and will use it solely to contact you about your potential participation in the study, and for no other purpose. The information you provide in this form will not be retained by the CRO after they make contact with you. No identifiable information you provide will be shared with or retained by Clairvoyant.